S13-497 Therapeutic monoclonal antibodies for AML and other cancers A team of Stanford researchers has developed humanized and chimeric mouse anti-human CD99 monoclonal antibodies with demonstrated activity against AML (acute myeloid leukemia) cells in vitro and in vivo. Jie Liu Ronald Levy Ravindra Majeti